SCHEMBL6445178

SCHEMBL6445178

CCN(C(=O)c1ccc2[nH]cnc2c1)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.54
KMT2A Q03164 3/20 0.54
ALDH1A1 P00352 7/20 0.54
HTT P42858 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.49
HPGD P15428 4/20 0.49
CTNNB1 P35222 1/20 0.46
WNT3A P56704 1/20 0.46
KDM4E B2RXH2 1/20 0.46
RAB9A P51151 1/20 0.46
ADORA2A P29274 1/20 0.46
GLA P06280 1/20 0.45
TSHR P16473 1/20 0.45
TP53 P04637 1/20 0.44
LMNA P02545 1/20 0.43
POLB P06746 2/20 0.42
MAPK1 P28482 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19994497 0.84 KDM4E (0.49) MEN1KMT2AALDH1A1HTTSMN1; SMN2
SCHEMBL1007145 0.82 HPGD (0.55) MEN1KMT2AALDH1A1HTTSMN1; SMN2
SCHEMBL12501973 0.80 MEN1 (0.55) MEN1KMT2AALDH1A1HTTSMN1; SMN2
SCHEMBL5142596 0.79 HSD17B2 (0.50) MEN1KMT2AALDH1A1HTTSMN1; SMN2
SCHEMBL13373337 0.79 KMT2A (0.58) MEN1KMT2AALDH1A1HTTHPGD
SCHEMBL3727867 0.78 HDAC6 (0.45) MEN1KMT2AALDH1A1HTTSMN1; SMN2
SCHEMBL14427603 0.76 MEN1 (0.66) MEN1KMT2AALDH1A1HTTSMN1; SMN2
SCHEMBL12647585 0.75 CTNNB1 (0.51) KMT2AALDH1A1HTTSMN1; SMN2HPGD
SCHEMBL1801614 0.75 ALDH1A1 (0.77) MEN1KMT2AALDH1A1HTTSMN1; SMN2
SCHEMBL15969237 0.74 CTNNB1 (0.79) ALDH1A1HTTSMN1; SMN2HPGDCTNNB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1499305-A2 USE OF EP4 RECEPTOR LIGANDS IN THE TREATMENT OF IL-6 INVOLVED DISEASES Pfizer Japan Inc. (JP) 2005-01-26 EP disclosed
WO-2003086371-A2 USE OF EP4 RECEPTOR LIGANDS IN THE TREATMENT OF IL-6 INVOLVED DISEASES PFIZER JAPAN INC. (JP) 2003-10-23 WO disclosed